Kaiso Logo
Location IconOffice 205 N Michigan Ave, Chicago, Illinois 60601, USA
YouTubeInstagramLinkedIn

We Accept

Payment MethodPayment MethodPayment MethodPayment MethodPayment MethodPayment Method

About

  • About us
  • What We Believe
  • Our Mission
  • Blogs & News

Company

  • Privacy Policy
  • Terms & Conditions
  • GDPR Policy
  • Disclaimer
  • Return & Refund Policy
  • Delivery Formats
  • Cookie Policy

Contact Us

  • Request for Consultation
  • Contact Us
  • Career
  • How to Order
  • Become a Reseller
  • FAQs

Contact Detail

Phone icon+1 872 219 0417
Email icon[email protected]

Keep in touch

Sign up for emails

Services

    Syndicate Reports
    Custom Report Solutions
    Full Time Engagement Models (FTE)
    Strategic Growth Solutions
    Consulting Services

Industries

    Popular Reports

      Healthcare IT
      Consumer Electronics
      Renewable and Specialty Chemicals
      Engineering, Equipment and Machinery
      Nutraceuticals and Wellness Foods
      Green, Alternative, and Renewable Energy

      Semiconductors
      Electric and Hybrid Vehicles
      Enterprise and Consumer IT Solutions
      Commercial Aviation
      Financial Services

    © 2025 Kaiso Research and Consulting. All Rights Reserved.

    ISO 9001 : 2015

    Privacy PolicyTerms & ConditionsHow to OrderSiteMap
    +1 872 219 0417[email protected]
    KAISO Logo
    Services
    Dropdown
    Industries
    Dropdown
    Report StoreConsulting Services
    Dropdown
    Blogs & NewsAbout Us
    Dropdown
    Logo
    Search
    Services►
    Industries►
    Report Store
    Consulting Services►
    Blogs & News
    About Us►
    Report image for Global Mycotoxin Testing Market Size, Opportunity Analysis and Forecast, 2025-2035

    Global Mycotoxin Testing Market Size, Trend & Opportunity Analysis Report, by Technology (HPLC-based, LC-MS/MS-based, Immunoassay-based, Other Technologies), Pathogen Type (Aflatoxins, Ochratoxin A, Patulin, Fusarium Toxins, Other Mycotoxins), and Forecast, 2025-2035

    Report Code: LSDB471Author Name: Isha PaliwalPublication Date: September 2025Pages: 295
    Available In:
    Available format: PDFAvailable format: ExcelAvailable format: Word
    KAISO Research and Consulting

    Global Mycotoxin Testing Market Size, Opportunity Analysis and Forecast, 2025-2035

    Publication Date: Sep 22, 2025Pages: 295

    IDENTIFY GROWTH & OPPORTUNITY

    Gain actionable insights to capture market opportunities and stay ahead of the competition.

    Consultation

    Tailor this report to your exact business needs with our customization service.

    Frequently Asked Question(FAQ) :

    The market was valued at USD 3.46 billion in 2024 and is anticipated to reach USD 6.50 billion by 2035, expanding at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period of 2025–2035.

    LC-MS/MS-based testing is the dominating segment and the industry gold standard. It is preferred for its high sensitivity, resolution, and multi-analyte quantification capabilities, which allow laboratories to meet the stringent regulatory thresholds set by the EU and US.

    Growth is primarily driven by stringent global regulatory frameworks (enforced by authorities like EFSA, USDA, and FAO), the expansion of global food trade, rising consumer awareness of foodborne hazards, and the critical need to protect livestock productivity from contaminated animal feed.

    The Aflatoxin segment leads the pathogen category. This is due to the high toxicity of aflatoxins (linked to human liver cancer) and their prevalence in high-volume global trade commodities such as maize, peanuts, and tree nuts, which are subject to strict international safety limits.

    Industry practitioners are increasingly integrating mycotoxin testing results with blockchain platforms to enhance transparency and trust across the food supply chain. This digital integration helps minimize trade disputes in cross-border transactions and reinforces brand equity.

    The Asia-Pacific region is the fastest-growing market. This growth is fueled by a surge in agricultural exports from countries like China and India, the tightening of domestic safety standards to align with international norms, and increasing investments in laboratory infrastructure.

    The high capital cost of equipment (like LC-MS/MS), the need for highly skilled personnel, and the complexity of multi-toxin detection act as significant barriers. These factors often limit the adoption of advanced testing methods among smaller processors and in emerging economies.

    The rise of point-of-care diagnostics, such as handheld immunoassay kits and biosensors, allows farmers and grain collectors to conduct on-site testing. These innovations enable early intervention, reduce dependency on central laboratories, and lower operational costs for frontline stakeholders.

    This segment is growing rapidly due to the expanding livestock industry and increased scrutiny of animal feed. Fusarium toxins like deoxynivalenol (DON) pose significant threats to animal health and productivity, prompting feed manufacturers to adopt rigorous testing protocols to ensure supply continuity.

    Recent innovations include Agilent’s next-generation high-throughput LC-MS/MS platform, R-Biopharm’s multiplex ELISA kits capable of detecting five toxins simultaneously, and Neogen’s handheld kits for on-site ochratoxin A detection. Additionally, companies like Eurofins and SGS are expanding their laboratory footprints in major export hubs like Brazil and the Asia-Pacific.